DEA Places Synthetic Opiate Into Schedule II
The Drug Enforcement Administration placed the synthetic opiate thiafentanil into Schedule II of the Controlled Substances Act, in a final rule (here). Effective Aug. 26, thiafentanil is subject to new registration, labeling, recordkeeping, and import and export requirements. DEA is accepting comments on the rule until Sept. 26.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(Federal Register 08/26/16)